Back to Journals » Drug Design, Development and Therapy » Volume 9

Brentuximab vedotin for treatment of relapsed or refractory malignant lymphoma: results of a systematic review and meta-analysis of prospective studies

Total article views   HTML views PDF downloads Totals
10,622 Dovepress* 9,145+ 1,912 11,057
PubMed Central* 1,477 621 2,098
Totals 10,622 2,533 13,155
*Since 20 April 2015
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar